In March, the FDA for the first time approved a naloxone nasal spray, sold under the Narcan brand, for use without a prescription. Austrian political party announces wrong winner of election ...
The approval comes nearly two months after the U.S. health regulator approved the prescription-free sale of Emergent Biosolutions' Narcan nasal spray, which is a naloxone-based drug used to reverse ...
"On the heels of the FDA's recent approval of the first over-the-counter opioid reversal agent [Narcan], the availability ... Health News // 4 days ago FDA approves second RSV vaccine for people ...
In the latest federal push, the FDA recently approved Narcan to be sold over the counter. The change will allow the new version of the drug to be stocked in grocery stores, vending machines and ...
U.S. health regulators on Monday approved a new easy-to-use version of a medication to reverse overdoses caused by fentanyl ...
Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak ... free sale of Emergent Biosolutions' (EBS.N) Narcan nasal spray, which is a naloxone-based drug ...
"On the heels of the FDA's recent approval of the first over-the-counter opioid reversal agent [Narcan], the availability of nalmefene nasal spray places a new prescription opioid reversal option ...
In March, the FDA for the first time approved a naloxone nasal spray, sold under the Narcan brand, for use without a prescription. The FDA press release stated that drugs like fentanyl accounted ...
In March, the FDA, for the first time, approved a naloxone nasal spray, sold under the Narcan brand, for use without a prescription. The FDA press release stated that drugs like fentanyl accounted ...
In March, the FDA, for the first time, approved a naloxone nasal spray, sold under the Narcan brand, for use without a prescription. The FDA press release stated that drugs like fentanyl accounted ...
The Food and Drug Administration on Monday said that it had given regulatory approval to a nasal spray that has proven ...
New HIV infection rates drop thanks to progress in young people, but US still not on track In March, the FDA, for the first time, approved a naloxone nasal spray, sold under the Narcan brand ...
